EFG Asset Management (Americas)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,693
| Closed | -$305K | – | 133 |
|
|
2022
Q3 | $305K | Sell |
3,693
-4
| -0.1% | -$330 | 0.08% | 115 |
|
|
2022
Q2 | $352K | Sell |
3,697
-709
| -16% | -$67.5K | 0.08% | 112 |
|
|
2022
Q1 | $519K | Sell |
4,406
-515
| -10% | -$60.7K | 0.1% | 110 |
|
|
2021
Q4 | $638K | Sell |
4,921
-281
| -5% | -$36.4K | 0.11% | 108 |
|
|
2021
Q3 | $589K | Buy |
5,202
+208
| +4% | +$23.6K | 0.1% | 109 |
|
|
2021
Q2 | $517K | Buy |
4,994
+778
| +18% | +$80.5K | 0.1% | 114 |
|
|
2021
Q1 | $353K | Buy |
4,216
+922
| +28% | +$77.2K | 0.07% | 121 |
|
|
2020
Q4 | $301K | Sell |
3,294
-156
| -5% | -$14.3K | 0.06% | 120 |
|
|
2020
Q3 | $275K | Buy |
3,450
+254
| +8% | +$20.2K | 0.06% | 123 |
|
|
2020
Q2 | $221K | Buy |
+3,196
| New | +$221K | 0.06% | 120 |
|
|
2017
Q4 | – | Sell |
-8,340
| Closed | -$304K | – | 134 |
|
|
2017
Q3 | $304K | Sell |
8,340
-228
| -3% | -$8.31K | 0.12% | 123 |
|
|
2017
Q2 | $338K | Buy |
+8,568
| New | +$338K | 0.13% | 104 |
|